Siemens to Showcase Infectious Disease Portfolio at ECCMID 2012

Siemens Healthcare Diagnostics is to showcase its extensive portfolio of infectious disease testing capabilities at the 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in London, England from March 31 - April 3 (Booth #441).

The exhibit will be themed “Innovation. Powered for Infectious Disease Solutions” and will feature innovative products designed to address the current and growing demands of infectious disease testing from screening and diagnosis, to susceptibility testing, genotyping, therapy selection and monitoring. Siemens will also be showing customized workflow options, assays to help clinicians improve patient care, and clinically-validated, expert-based software solutions that support personalized medicine.

“Infectious disease is a leading cause of death worldwide, making it critical that clinicians have access to diagnostic solutions that provide trustworthy results, which ultimately contribute to optimal patient outcomes,” said Christoph Gauer, PhD, CEO, Molecular and Microbiology Business Segment, Siemens Healthcare Diagnostics. “Visitors to our ECCMID booth will learn how Siemens can help them improve the delivery of vital information healthcare providers require to care for their patients impacted by infectious disease.”

If you are interested in the latest innovations in liver health, microbiology and molecular diagnostic solutions, the Siemens booth at ECCMID should be well worth a visit.